IMPROVING ONCOLOGY INVESTIGATE WITH INTEGRATED KRAS ASSAY EXPERT SERVICES AND RAS ASSAYS

while in the fast evolving area of oncology analysis, correct and effective mutation screening is essential for building focused therapies. The KRAS solutions Platform performs a pivotal role During this landscape by offering in depth methods for KRAS mutation profiling and Assessment. KRAS mutations, present in around ninety five% of RAS-relevant